Literature DB >> 22396410

Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.

Richard Exley1, J Michael McIntosh, Michael J Marks, Uwe Maskos, Stephanie J Cragg.   

Abstract

Polymorphisms in the gene for the α5 nicotinic acetylcholine receptor (nAChR) subunit are associated with vulnerability to nicotine addiction. However, the underlying normal functions of α5-containing nAChRs in the brain are poorly understood. Striatal dopamine (DA) transmission is critical to the acquisition and maintenance of drug addiction and is modulated strongly by nicotine acting at heteromeric β2-containing (β2*) nAChRs. We explored whether α5 subunits, as well as α4, α6, and β3 subunits, participate in the powerful regulation of DA release probability by β2* nAChRs in nucleus accumbens (NAc) core and in dorsal striatum [caudatoputamen (CPu)]. We detected evoked dopamine release using fast-scan cyclic voltammetry at carbon-fiber microelectrodes in striatal slices from mice with deletions of α4, α5, α6, or β3 subunits. We show that the nAChR subtypes that dominantly regulate dopamine transmission depend critically upon α5 subunits in the dorsal CPu in α4α5(non-α6)β2-nAChRs but not in NAc core, where α4α6β2β3-nAChRs are required. These data reveal the distinct populations of nAChRs that govern DA transmission in NAc core versus dorsal CPu. Furthermore, they indicate that α5 subunits are critical to the regulation of DA transmission by α4β2* nAChRs in regions of striatum associated with habitual and instrumental responses (dorsal CPu) rather than pavlovian associations (NAc).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396410      PMCID: PMC3742968          DOI: 10.1523/JNEUROSCI.4985-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors.

Authors:  U Maskos; B E Molles; S Pons; M Besson; B P Guiard; J-P Guilloux; A Evrard; P Cazala; A Cormier; M Mameli-Engvall; N Dufour; I Cloëz-Tayarani; A-P Bemelmans; J Mallet; A M Gardier; V David; P Faure; S Granon; J-P Changeux
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

2.  Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.

Authors:  L M Marubio; M del Mar Arroyo-Jimenez; M Cordero-Erausquin; C Léna; N Le Novère; A de Kerchove d'Exaerde; M Huchet; M I Damaj; J P Changeux
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

3.  Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.

Authors:  Sarah Threlfell; Michael A Clements; Tansi Khodai; Ilse S Pienaar; Richard Exley; Jürgen Wess; Stephanie J Cragg
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

Review 4.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

5.  Firing modes of midbrain dopamine cells in the freely moving rat.

Authors:  B I Hyland; J N J Reynolds; J Hay; C G Perk; R Miller
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.

Authors:  Changhai Cui; T K Booker; Roberta S Allen; Sharon R Grady; Paul Whiteaker; Michael J Marks; Outi Salminen; Theresa Tritto; Christopher M Butt; W R Allen; Jerry A Stitzel; J Michael McIntosh; Jim Boulter; Allan C Collins; Stephen F Heinemann
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

7.  Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors.

Authors:  Sharon R Grady; Outi Salminen; J Michael McIntosh; Michael J Marks; Allan C Collins
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

8.  Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

Authors:  Richard Exley; Michael A Clements; Henrike Hartung; J Michael McIntosh; Stephanie J Cragg
Journal:  Neuropsychopharmacology       Date:  2007-11-21       Impact factor: 7.853

9.  Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.

Authors:  Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis J David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco M Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

10.  Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.

Authors:  Outi Salminen; Jennifer A Drapeau; J Michael McIntosh; Allan C Collins; Michael J Marks; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2007-03-06       Impact factor: 4.436

View more
  46 in total

1.  Nicotinic receptors regulate the dynamic range of dopamine release in vivo.

Authors:  Jessica L Koranda; Jackson J Cone; Daniel S McGehee; Mitchell F Roitman; Jeff A Beeler; Xiaoxi Zhuang
Journal:  J Neurophysiol       Date:  2013-10-02       Impact factor: 2.714

2.  Medial habenula output circuit mediated by α5 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus.

Authors:  Yun-Wei A Hsu; Lynne Tempest; Lely A Quina; Aguan D Wei; Hongkui Zeng; Eric E Turner
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

3.  The nicotinic α5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the α4β2* neuronal nicotinic receptor.

Authors:  Xiaochun Jin; Isabel Bermudez; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2013-11-01       Impact factor: 4.436

4.  Chrna5-Expressing Neurons in the Interpeduncular Nucleus Mediate Aversion Primed by Prior Stimulation or Nicotine Exposure.

Authors:  Glenn Morton; Nailyam Nasirova; Daniel W Sparks; Matthew Brodsky; Sanghavy Sivakumaran; Evelyn K Lambe; Eric E Turner
Journal:  J Neurosci       Date:  2018-06-28       Impact factor: 6.167

Review 5.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 6.  Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.

Authors:  Mark J Ferris; Erin S Calipari; Jordan T Yorgason; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2013-05-06       Impact factor: 4.418

Review 7.  Dopamine's Effects on Corticostriatal Synapses during Reward-Based Behaviors.

Authors:  Nigel S Bamford; R Mark Wightman; David Sulzer
Journal:  Neuron       Date:  2018-02-07       Impact factor: 17.173

8.  Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing.

Authors:  Roger Cachope; Yolanda Mateo; Brian N Mathur; James Irving; Hui-Ling Wang; Marisela Morales; David M Lovinger; Joseph F Cheer
Journal:  Cell Rep       Date:  2012-07-11       Impact factor: 9.423

9.  Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

Authors:  C Morel; L Fattore; S Pons; Y A Hay; F Marti; B Lambolez; M De Biasi; M Lathrop; W Fratta; U Maskos; P Faure
Journal:  Mol Psychiatry       Date:  2013-12-03       Impact factor: 15.992

10.  Protein kinase D1-dependent phosphorylation of dopamine D1 receptor regulates cocaine-induced behavioral responses.

Authors:  Ning Wang; Ping Su; Ying Zhang; Jie Lu; Baoming Xing; Kai Kang; Wenqi Li; Yun Wang
Journal:  Neuropsychopharmacology       Date:  2013-12-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.